Omada Health
OMDA on Nasdaq. Omada sells virtual health care programs to employers and health plans. Market value $1.3bn.
Price checks use the past 12 months to June 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Look carefully before going further
Why it could be worth it
Read the warning sign in its own filings
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $1.35 of spare cash in the past 12 months. A savings account pays about $4.
The filings do not give us enough to work this out.
The filings do not give us enough to work this out.
Quality score: not known. Price score: 9 of 100. Our list needs 70 on quality and 60 on price.
$20.73 a share, 102% above its 1-year low
Over the past year the price has ranged from $10.28 to $26.92.
Pays no dividend
Prices from Tuesday’s close (6 October).
Five years of cash, in billions
| Revenue | |
| Revenue | $260m |
| Operating margin | |
| Operating margin | -4.6% |
| Debt to equity | |
| Debt to equity | 0.00 |
| Shares outstanding | |
| Shares outstanding | 0.06bn |
Health checks
- Free cash flow positive1 of 1 years
- Accounting looks honest (Beneish)Not enough data
- Financial strength (Piotroski)Not enough data
- Profit backed by cash (accruals)Not enough data
- Debt0.00× equity
- Revenue growth, five yearsUnknown
- Buying back its own sharesRoughly flat
The quarter to June 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $88 million last quarter, up 43% on a year ago.
- Profit: $5 million, after a loss of $5 million a year ago.
- 191% more shares than a year ago. Each share owns a bit less of the company.
| Quarter to | Amount |
|---|---|
| June 2025 | $61m |
| September 2025 | $68m |
| December 2025 | $76m |
| March 2026 | $78m |
| June 2026 | $88m |
| Quarter to | Amount |
|---|---|
| June 2025 | -$5m |
| September 2025 | -$3m |
| December 2025 | $5m |
| March 2026 | -$3m |
| June 2026 | $5m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 6 March 2026
- Next quarterly (estimated, 10-Q)
- 6 November 2026
Who owns it
None of the long-term investors we follow own it. 154 funds in all.
Largest holders overall
- Revelation Capital Management$107mCut
- Divisadero Street Capital Management, LP$83mCut
- American Century Companies$81mAdded
- Cigna Investments$76m
- Morgan Stanley$61mAdded
- FMR$61mCut
- NVP Associates$56m
- BlackRock$49mAdded
- Vanguard Capital Management$42mAdded
- Millennium Management$38mAdded
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
6 investors own more than 5%.
- Michael BoggsPassive investorat least 9.1%(filed with 7 related holders)Since 30 June 2025
- Divisadero Street Capital Management, LPPassive investorat least 6.3%−3.6 pts(filed with 4 related holders)Since 30 June 2026
- American Century Investment Management, Inc.Passive investorat least 6.2%(filed with 2 related holders)Since 30 June 2026
- The Cigna GroupPassive investorat least 5.8%(filed with 1 related holder)Since 30 June 2025
- FMR LLCPassive investorat least 5.6%−2.9 pts(filed with 1 related holder)Since 31 March 2026
- Benjamin A. HorowitzPassive investorat least 4.2%−1.9 pts(filed with 5 related holders)Since 31 March 2026
- Casey M TanseyPassive investorSold down below 5%Since 31 December 2025
| Holder | Stake | Since | |
|---|---|---|---|
Michael Boggs Passive investor | at least 9.1% (filed with 7 related holders) | 30 June 2025 | |
Divisadero Street Capital Management, LP Passive investor | at least 6.3%−3.6 pts (filed with 4 related holders) | 30 June 2026 | |
American Century Investment Management, Inc. Passive investor | at least 6.2% (filed with 2 related holders) | 30 June 2026 | |
The Cigna Group Passive investor | at least 5.8% (filed with 1 related holder) | 30 June 2025 | |
FMR LLC Passive investor | at least 5.6%−2.9 pts (filed with 1 related holder) | 31 March 2026 | |
Benjamin A. Horowitz Passive investor | at least 4.2%−1.9 pts (filed with 5 related holders) | 31 March 2026 | |
Casey M Tansey Passive investor | Sold down below 5% | 31 December 2025 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought shares on the open market in the last 12 months. 4 sold $12m, $8m of it under preset trading plans.
- Duffy Sean P.Chief Executive Officer, DirectorSoldunder a preset trading plan
- Date
- 1 October 2026
- Shares
- 17,258
- Price
- $20.68
- Value
- $356,915
- Duffy Sean P.Chief Executive Officer, DirectorSoldunder a preset trading plan
- Date
- 10 September 2026
- Shares
- 14,960
- Price
- $21.87
- Value
- $327,197
- Cook Steven L.Chief Financial OfficerSoldunder a preset trading plan
- Date
- 10 September 2026
- Shares
- 6,800
- Price
- $21.86
- Value
- $148,640
- Shao Wei-LiPresidentSoldunder a preset trading plan
- Date
- 10 September 2026
- Shares
- 4,036
- Price
- $21.85
- Value
- $88,206
- Gracey CraigChief Accounting OfficerSoldunder a preset trading plan
- Date
- 9 September 2026
- Shares
- 644
- Price
- $21.73
- Value
- $13,995
- Duffy Sean P.Chief Executive Officer, DirectorSoldunder a preset trading plan
- Date
- 1 September 2026
- Shares
- 21,572
- Price
- $23.62
- Value
- $509,465
- Cook Steven L.Chief Financial OfficerSoldunder a preset trading plan
- Date
- 27 August 2026
- Shares
- 1,108
- Price
- $25.00
- Value
- $27,700
- Shao Wei-LiPresidentSoldunder a preset trading plan
- Date
- 12 August 2026
- Shares
- 9,418
- Price
- $25.02
- Value
- $235,607
- Cook Steven L.Chief Financial OfficerSoldunder a preset trading plan
- Date
- 11 August 2026
- Shares
- 1,607
- Price
- $25.01
- Value
- $40,197
- Cook Steven L.Chief Financial OfficerSoldunder a preset trading plan
- Date
- 10 August 2026
- Shares
- 15,235
- Price
- $25.03
- Value
- $381,350
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 1 October 2026 | Duffy Sean P. Chief Executive Officer, Director | Sold under a preset trading plan | 17,258 | $20.68 | $356,915 |
| 10 September 2026 | Duffy Sean P. Chief Executive Officer, Director | Sold under a preset trading plan | 14,960 | $21.87 | $327,197 |
| 10 September 2026 | Cook Steven L. Chief Financial Officer | Sold under a preset trading plan | 6,800 | $21.86 | $148,640 |
| 10 September 2026 | Shao Wei-Li President | Sold under a preset trading plan | 4,036 | $21.85 | $88,206 |
| 9 September 2026 | Gracey Craig Chief Accounting Officer | Sold under a preset trading plan | 644 | $21.73 | $13,995 |
| 1 September 2026 | Duffy Sean P. Chief Executive Officer, Director | Sold under a preset trading plan | 21,572 | $23.62 | $509,465 |
| 27 August 2026 | Cook Steven L. Chief Financial Officer | Sold under a preset trading plan | 1,108 | $25.00 | $27,700 |
| 12 August 2026 | Shao Wei-Li President | Sold under a preset trading plan | 9,418 | $25.02 | $235,607 |
| 11 August 2026 | Cook Steven L. Chief Financial Officer | Sold under a preset trading plan | 1,607 | $25.01 | $40,197 |
| 10 August 2026 | Cook Steven L. Chief Financial Officer | Sold under a preset trading plan | 15,235 | $25.03 | $381,350 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
1 serious warning sign in Omada Health’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 6 Mar 2026, plus the 10-Q filed 7 Aug 2026 and 3 later 8-Ks.
Weak checks on its own accounts
SeriousThe company said its checks on its own accounts did not work at the end of its latest quarter. Mistakes could slip into the numbers.
“Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of June 30, 2026, our disclosure controls and procedures were not effective at the reasonable assurance level because of the material weakness in our internal control over financial reporting described below.”
Show the full paragraph
Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our principal executive officer and principal financial officer concluded that, as of June 30, 2026, our disclosure controls and procedures were not effective at the reasonable assurance level because of the material weakness in our internal control over financial reporting described below.
From the 10-Q filed 7 August 2026, Part I, Item 4. Controls and Procedures. Read it in the filing
One big customer
Worth knowingOne customer brings in a big share of sales: 33% last year. Losing that customer would hurt.
“For the year ended December 31, 2025, we had one health plan or PBM that accounted for 32% of our revenue, and a second health plan or PBM that accounted for 33% of our revenue.”
From the 10-K filed 6 March 2026, Item 1A. Risk Factors. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.